The independent source for health policy research, polling, and news.
141-160 of 3,363 results
Inquiries lead from one federal office to the next, with no clear answers. At one Army Contracting Command, a protocol office employee says that “voicemail has been down for months.” And the email address listed for fielding media inquiries? “The army stopped using the email address about eight years ago.”
The Biden administration is getting rid of several policies implemented by Trump-era appointees that restricted enrollment. Federal officials now say states can no longer charge premiums to low-income residents enrolled in Medicaid and have ruled out work requirements.
Problems with California’s new Medicaid prescription drug program are preventing thousands of patients from getting their medications, including some life-saving ones. State officials say they’re working on fixes.
Among the 764 hospitals hit with a 1% reduction in Medicare payments this year for having high numbers of patient infections and avoidable complications are more than three dozen that Medicare also ranks as among the best in the country.
Investigators allege a Texas company that arranges spine surgery and other medical care for people injured in car crashes accepted bribes in violation of 1960s-era racketeering law.
The backroom deal with politically connected Kaiser Permanente, which infuriated other Medi-Cal health plans, allows the health care giant to continue selecting the enrollees it wants.
Some practitioners object to the way upfront cost estimates are designed, saying they could affect access to care and are burdensome. Other experts disagree.
The No Surprises Act protects patients from surprise out-of-network bills. But there are caveats. For instance, these protections apply only to care in a hospital. This episode breaks it all down.
The covid-19 pandemic exposed how state and local governments’ severely outdated technology can hinder unemployment benefits, food stamps, Medicaid, vaccine registrations, and the flow of other critical information. Now, with hefty federal pandemic relief and unexpected tax windfalls, states may finally have the chance to revamp their information technology for health care and social services. But can they?
Southern California correspondent Bernard J. Wolfson answers questions about the health coverage deals available on California’s Affordable Care Act marketplace during Radio Bilingüe’s news program “Línea Abierta.”
Mass General Brigham’s $2.3 billion expansion plan is raising state officials’ concerns that it will reduce competition and raise the price of care in Massachusetts. It also signals a national shift from a focus on hospital mergers and purchases of physician practices — which boost the cost of care — to individual hospitals’ expansions to gain a bigger share of the market.
KHN Editor-in-Chief Elisabeth Rosenthal weighs in on the January installment of KHN-NPR's Bill of the Month, in which a family gets burned over a visit to the emergency room.
KHN gives readers a chance to comment on a recent batch of stories.
A St. Louis-area toddler burned his hand on the stove, and his mom took him to the ER on the advice of her pediatrician. He wasn’t seen by a doctor, and the dressing on the wound wasn’t changed. The bill was more than a thousand dollars.
The top 12 states using antibody therapies produced by Regeneron and Lilly — which research shows don’t work against the omicron variant — include several Southern states with some of the nation’s lowest vaccination rates, but also California, which ranks among the top 20 for fully vaccinated residents.
The Little Shell Tribe of Chippewa Indians of Montana plans to open the nation’s newest Indian Health Service clinic in Great Falls on Jan. 31 — marking the first time the tribe will have its culture reflected in health care offerings.
The Department of Health and Human Services issued preliminary rules regarding health insurance marketplaces that aim to deter fraudulent sign-ups for coverage. Experts say the agency’s action indicates a problem exists.
Telling insurance companies to pay for rapid covid-19 tests is just the latest covid-related cost the federal government expects them to bear. But who really ends up paying for it?
High demand for covid screening and scarce supply have opened the door to bad actors, and officials in some states are sounding the alarm about dubious street testing operators that could put people’s personal data, their health or wallets at risk.
Medicare officials tentatively plan to restrict the use of a controversial Alzheimer’s drug to only those patients participating in clinical trials, while the Department of Health and Human Services looks into lowering the monthly Medicare Part B premium. Meanwhile, covid confusion still reigns, as the Biden administration moves, belatedly, to make more masks and tests available. Joanne Kenen of Politico and the Johns Hopkins Bloomberg School of Public Health, Sarah Karlin-Smith of the Pink Sheet and Rachel Cohrs of Stat join KHN’s Julie Rovner to discuss these issues and more.
© 2026 KFF